Elevance Health to reaffirm FY2023 guidance and discuss 2027 targets

Elevance Health, Inc.

Investor conference on March 23, 2023; webcast at 8:00 a.m. ET.
FY2023 guidance reaffirmed; no new financial figures provided in filing.
Long-term financial targets through 2027 to be discussed.
No specific numbers or changes disclosed; filing is procedural FD disclosure.

item 7.01

Elevance Health, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-076793

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.